MedTrace Logo

Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation

NCT05996159 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-05-20

No results posted yet for this study

Summary

This study aims to investigate the effect of reducing ablation time for a hybrid approach of vHPSD and AI-guided ablation using the QDOT Micro catheter in PVI among patients with PAF.

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

DEVICE

QDOT MicroTM catheter

Novel high power-short duration ablation catheter for atrial fibrillation

DEVICE

AI-guided ablation only for PVI

Ablation is the removal or destruction of something from an object by vaporization, chipping, erosive processes, or by other means.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Eue-Keun Choi, M.D. Ph.D. · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-07
Primary Completion
2026-07-30
Completion
2027-05-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05996159 on ClinicalTrials.gov